JP2013527854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527854A5 JP2013527854A5 JP2013509404A JP2013509404A JP2013527854A5 JP 2013527854 A5 JP2013527854 A5 JP 2013527854A5 JP 2013509404 A JP2013509404 A JP 2013509404A JP 2013509404 A JP2013509404 A JP 2013509404A JP 2013527854 A5 JP2013527854 A5 JP 2013527854A5
- Authority
- JP
- Japan
- Prior art keywords
- mannan
- composition
- composition according
- antigen
- oxidized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000057 Mannan Polymers 0.000 claims 17
- 238000000034 method Methods 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 125000003172 aldehyde group Chemical group 0.000 claims 3
- JPVHHMBWAVKWTE-UHFFFAOYSA-N 2-aminonaphthalene-1,3,6-trisulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=CC2=C(S(O)(=O)=O)C(N)=C(S(O)(=O)=O)C=C21 JPVHHMBWAVKWTE-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000001268 conjugating effect Effects 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33308610P | 2010-05-10 | 2010-05-10 | |
| US61/333,086 | 2010-05-10 | ||
| AU2010901997A AU2010901997A0 (en) | 2010-05-10 | Immunostimulatory and vaccine compositions | |
| AU2010901997 | 2010-05-10 | ||
| AU2010904060A AU2010904060A0 (en) | 2010-09-09 | Immunostimulatory and vaccine compositions | |
| AU2010904060 | 2010-09-09 | ||
| PCT/AU2011/000542 WO2011140595A2 (en) | 2010-05-10 | 2011-05-10 | Immunostimulatory and vaccine compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527854A JP2013527854A (ja) | 2013-07-04 |
| JP2013527854A5 true JP2013527854A5 (enExample) | 2014-06-26 |
| JP6096111B2 JP6096111B2 (ja) | 2017-03-15 |
Family
ID=44914748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509404A Expired - Fee Related JP6096111B2 (ja) | 2010-05-10 | 2011-05-10 | 免疫刺激組成物及びワクチン組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9597392B2 (enExample) |
| EP (1) | EP2574170A4 (enExample) |
| JP (1) | JP6096111B2 (enExample) |
| CN (1) | CN102985095B (enExample) |
| AU (1) | AU2011226992B2 (enExample) |
| BR (1) | BR112012028893A2 (enExample) |
| CA (1) | CA2798856C (enExample) |
| RU (1) | RU2578420C2 (enExample) |
| WO (1) | WO2011140595A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2170384T3 (en) | 2007-07-02 | 2016-07-25 | Etubics Corp | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF AN adenovirus vector for use in higher vaccination |
| IN2014CN04251A (enExample) * | 2011-11-09 | 2015-07-17 | Ascend Biopharmaceuticals Ltd | |
| US9605276B2 (en) | 2012-08-24 | 2017-03-28 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| ES2503516B1 (es) | 2013-04-03 | 2015-09-09 | Inmunotek, S.L. | Complejo inmunogénico para vacunación y método de obtención |
| JP6647315B2 (ja) | 2015-01-09 | 2020-02-14 | イーチュービクス コーポレイション | 組み合わせ免疫療法のための方法および組成物 |
| EP3256140B1 (en) | 2015-01-09 | 2020-04-01 | Etubics Corporation | Compositions for ebola virus vaccination |
| EP3286213B1 (en) | 2015-04-20 | 2021-08-04 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| EP3474884A4 (en) | 2016-06-22 | 2020-08-19 | Alkermes, Inc. | COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNOSTIMULANT AND ANTI-INFLAMMATORY PROPERTIES OF IL-10 |
| KR20210044805A (ko) | 2018-08-06 | 2021-04-23 | 닐슨 바이오사이언스, 아이엔씨. | 사마귀의 치료 |
| US11197910B1 (en) * | 2020-08-19 | 2021-12-14 | Vitruviae LLC | Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases |
| AU2022234358A1 (en) * | 2021-03-12 | 2023-10-19 | Children's Medical Center Corporation | Polysaccharide adjuvants for virus vaccines |
| CN113616799B (zh) * | 2021-07-13 | 2023-08-29 | 中国科学院长春应用化学研究所 | 一种疫苗载体、其制备方法及应用 |
| JPWO2024117232A1 (enExample) * | 2022-11-30 | 2024-06-06 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362951A (en) | 1965-12-21 | 1968-01-09 | Farkas Alexander | Polysaccharide product derived from the juice of the aloe plant and methods for preparing same |
| US5308838A (en) | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
| US4735935A (en) | 1985-12-17 | 1988-04-05 | Carrington Laboratories, Inc. | Process for preparation of aloe products products, produced thereby and compositions thereof |
| US4861761A (en) | 1984-06-28 | 1989-08-29 | Dr. Madis Laboratories, Inc. | Aloeferon isolation, manufacturing and its applications |
| FR2573656B1 (fr) * | 1984-11-29 | 1987-02-27 | Sanofi Sa | Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose |
| US6054438A (en) | 1987-01-07 | 2000-04-25 | Imperial Cancer Research Technology Limited | Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
| JPH02501828A (ja) | 1987-01-07 | 1990-06-21 | インペリアル・キヤンサー・リサーチ・テクノロジー・リミテツド | プローブ |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5744144A (en) | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| DE69536091D1 (de) | 1994-01-27 | 2010-09-09 | Univ Massachusetts Medical | Immunisierung durch Impfung von DNS Transkriptionseinheit |
| US5939400A (en) | 1996-02-26 | 1999-08-17 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for induction of suppressive T cell response |
| AU3210997A (en) | 1996-05-24 | 1997-12-09 | University Of Maryland At Baltimore | Dna vaccines for eliciting a mucosal immune response |
| US5824659A (en) | 1996-09-04 | 1998-10-20 | Board Of Regents, The University Of Texas System | Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation |
| JP2001507352A (ja) | 1996-12-20 | 2001-06-05 | メルク エンド カンパニー インコーポレーテッド | 組換えパピローマウイルスワクチンの組成物 |
| WO1998050527A1 (en) | 1997-05-08 | 1998-11-12 | Biomira Inc. | Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| AU760669B2 (en) | 1998-04-28 | 2003-05-22 | Galenica Pharmaceuticals, Inc. | Polysaccharide-antigen conjugates |
| IL125608A0 (en) | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| JP2003510094A (ja) | 1999-09-08 | 2003-03-18 | トランジェーヌ、ソシエテ、アノニム | Ｍｕｃ−１由来のペプチド |
| JP2003533181A (ja) | 2000-02-01 | 2003-11-11 | ジ・オースティン・リサーチ・インスティテュート | ムチン−１誘導抗原および免疫療法におけるその使用 |
| WO2008037033A1 (en) * | 2006-09-29 | 2008-04-03 | The Macfarlane Burnet Institute For Medical Research And Public Health Limited | Flu vaccine admixture of mannan and flu antigen |
| AUPQ797700A0 (en) * | 2000-06-06 | 2000-06-29 | Austin Research Institute, The | Vaccine |
| US7196072B2 (en) | 2000-07-10 | 2007-03-27 | University Of Mississippi | High molecular weight polysaccharide fraction from Aloe vera with immunostimulatory activity |
| EP1307213B1 (en) * | 2000-08-10 | 2004-04-28 | Ocean Nutrition Canada Ltd. | Chlorella preparations exhibiting immunomodulating properties |
| DK1545597T3 (da) | 2002-08-15 | 2011-01-31 | 3M Innovative Properties Co | Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons |
| US7906620B2 (en) | 2002-08-16 | 2011-03-15 | Yeda Research And Development Co. Ltd. | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| WO2005044861A1 (en) | 2003-10-31 | 2005-05-19 | Wyeth Holdings Corporation | Polysaccharides of helicobacter pylori |
| EP1697515A4 (en) * | 2003-11-12 | 2008-02-06 | Austin Research Inst | CONJUGATE DNA-EXCIPIENT |
| US20060084629A1 (en) | 2004-10-15 | 2006-04-20 | Alvin Needleman | Immune system activating formula composed of selected long chain polysaccharides from natural sources |
| JP2006241020A (ja) * | 2005-03-01 | 2006-09-14 | Asahi Breweries Ltd | 免疫系賦活剤 |
| JP2006241023A (ja) * | 2005-03-01 | 2006-09-14 | Asahi Breweries Ltd | 消化管組織における抗菌ペプチドの発現誘導または産生促進剤 |
| WO2007100634A2 (en) | 2006-02-22 | 2007-09-07 | 3M Innovative Properties Company | Immune response modifier conjugates |
| WO2008105773A2 (en) | 2006-03-31 | 2008-09-04 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
| JP2009544291A (ja) | 2006-07-25 | 2009-12-17 | フォージー ヴァクシンズ ピーティーワイ エルーティーディー | ムチン１（ｍｕｃ１）ｔ細胞エピトープ由来ペプチド含有癌ワクチン |
| WO2008039432A1 (en) | 2006-09-26 | 2008-04-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for enhancing an adjuvant |
| US20080149123A1 (en) | 2006-12-22 | 2008-06-26 | Mckay William D | Particulate material dispensing hairbrush with combination bristles |
-
2011
- 2011-05-10 AU AU2011226992A patent/AU2011226992B2/en not_active Ceased
- 2011-05-10 US US13/696,853 patent/US9597392B2/en not_active Expired - Fee Related
- 2011-05-10 CA CA2798856A patent/CA2798856C/en not_active Expired - Fee Related
- 2011-05-10 BR BR112012028893A patent/BR112012028893A2/pt not_active Application Discontinuation
- 2011-05-10 WO PCT/AU2011/000542 patent/WO2011140595A2/en not_active Ceased
- 2011-05-10 EP EP11779973.4A patent/EP2574170A4/en not_active Withdrawn
- 2011-05-10 JP JP2013509404A patent/JP6096111B2/ja not_active Expired - Fee Related
- 2011-05-10 CN CN201180033660.4A patent/CN102985095B/zh not_active Expired - Fee Related
- 2011-05-10 RU RU2012152952/15A patent/RU2578420C2/ru not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527854A5 (enExample) | ||
| Stephens et al. | Considerations for a respiratory syncytial virus vaccine targeting an elderly population | |
| Rajao et al. | Swine as a model for influenza A virus infection and immunity | |
| HK1216894A1 (zh) | 多價結合蛋白組合物 | |
| JP2015171368A5 (enExample) | ||
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| WO2016109792A8 (en) | Novel multivalent nanoparticle-based vaccines | |
| WO2012051211A3 (en) | Antigen delivery platforms | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2011529686A5 (enExample) | ||
| CN110337449A (zh) | 抗pd-l1抗体及其应用 | |
| WO2014009438A3 (en) | Mycobacterial antigen vaccine | |
| JP2013079285A5 (enExample) | ||
| MX2013013111A (es) | Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma. | |
| CY1118080T1 (el) | Σωματιδια απελευθερωσης που ομοιαζουν με ιικα σωματιδια για αυτοαντιγραφικα rna μορια | |
| JP2014515039A5 (enExample) | ||
| WO2017015463A3 (en) | Infectious disease vaccines | |
| WO2012009544A3 (en) | Domain insertion immunoglobulin | |
| WO2011039368A3 (en) | Dll4-binding molecules | |
| JP2015524422A5 (enExample) | ||
| EP2727939A3 (en) | VEGF-binding molecules | |
| WO2009124309A3 (en) | Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same | |
| WO2008002663A3 (en) | Immunogenic protein constructs | |
| EP2672992A4 (en) | FOR A HEPATITIS B-VIRUS CORE PROTEIN, CODING NUCLEIC ACID MOLECULE AND VACCINE WITH IT | |
| WO2010129339A3 (en) | Compositions and methods for enhancing antigen-specific immune responses |